Characterization of the cachexia pathway in pancreatic ductal adenocarcinoma | Caris Life Sciences
Home / Research / Publications / Characterization of the cachexia pathway in pancreatic ductal adenocarcinoma

Publications

Characterization of the cachexia pathway in pancreatic ductal adenocarcinoma

  • Cancer cachexia is characterized by progressive weight loss and skeletal muscle degradation, contributing to 33% of pancreatic ductal adenocarcinoma (PDAC) deaths.
  • Novel therapeutics targets of myostatin in the myostatinactivin pathway have been shown to reverse cachexia.
  • Here, we present a large clinical and molecular characterization of the myostatin-activin pathway in PDAC
Download Publication
Learn More
Name(Required)